SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | |
---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-2.31 Cr | ₹-1.26 Cr | - |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-2.31 Cr |
Mar2024 | ₹-1.26 Cr |
Mar2023 | - |
How is Deferred Tax Assets / Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-2.31 Cr | Negative | |
Mar2024 | ₹-1.26 Cr | 0 | |
Mar2023 | - | - |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,765.3 Cr | 3.1% | -8.9% | -30.7% | Stock Analytics | |
SYNGENE INTERNATIONAL | ₹26,896.2 Cr | 1.3% | -0.6% | -17.1% | Stock Analytics | |
SAGILITY INDIA | ₹21,009.8 Cr | -1.2% | 2.4% | NA | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹8,850.8 Cr | 7.3% | -1% | -17.6% | Stock Analytics | |
JUST DIAL | ₹7,171.4 Cr | 2.3% | -3.1% | -35% | Stock Analytics | |
AWFIS SPACE SOLUTIONS | ₹4,181.1 Cr | -0.5% | -9.1% | -22.7% | Stock Analytics |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | 3.1% |
-8.9% |
-30.7% |
SENSEX | 2% |
0.1% |
1.8% |
You may also like the below Video Courses